Dr. Schirmers studied law at the Ruhr-University in Bochum (Germany)then served as an assistant professor at the same institution and at the University of Passau (Germany). He later pursued a law internship in Bavaria and earned a J.D. in antitrust law. After serving as an assistant to, then as director of the executive board at HDI (now Talanx), and as a consultant and senior project leader at McKinsey & Co. Inc, Dr. Schirmers founded SHS, where he continues to serve as a partner and managing director.
(representative of the founding members)
In addition to acting as the chosen representative of the founding members to the board, Prof. Zeilhofer (a key opinion leader in the field of maxillofacial surgery) also serves as a medical advisor to AOT. Prof. Zeilhofer heads the department of Oral and Maxillofacial Surgery at the University Hospital in Basel (Switzerland) and the Cantonal Hospital and its affiliated research center in Aarau (Switzerland). In addition, Prof. Zeilhofer chairs the research group “Clinical Morphology and Biomedical Engineering” at the University Hospital in Basel, and is president of the Swiss Society of Oral and Maxillofacial Surgeons.
(Chairman of the Board)
Dr. Erich Platzer completed his medical studies and training at the University of Erlangen (Germany). Since 2001, he has worked as an investment advisor and is the co-founder of the venture capital company HBM BioVentures. He served for several years as the president of privately and publicly-traded biotech companies, amassed 10 years’ operational experience in the areas of product development and marketing, and was responsible for several strategic collaborations as the Head of Oncology at Roche. Currently, Dr. Platzer is chair of the board of directors at AOT AG and Cylene Pharmaceuticals, vice-chairman of mtm laboratories and a board member at Nereus and ProBiodrug.
Dr. Werner Berner received his bachelor of science in mechanical engineering from the Technical Institute of Brugg-Windisch (Switzerland) and his doctoral degree in physics from the University of Bern (Switzerland). He has held senior positions at international companies, where, among other things, he was responsible for establishing a production and supply chain for an orthopedic implants company. Dr. Berner is the founder and president of Berner Partners AG, a consulting and engineering company. He is also a member of the board of directors at various companies in the MedTech field, and is the chairman of the board of trustees at several foundations.
(Vice-President of the Board)
Dr. Peter Burckhardt is a trained chemist who earned his doctorate from the University of Basel (Switzerland.) He started his career in pharmaceutical research at Ciba-Geigy in 1984, and subsequently held several management positions in the areas of research, development, production, and communication. From 1996 to 1999 he was CEO of Ciba-Geigy’s Animal Health division in Germany. The CEO of the start-up incubator EVA in Basel, he is now a member of various administrative boards within the EVA portfolio.